Viveve Medical (VIVE) Tops Q3 EPS by 2c

Viveve Medical (NASDAQ: VIVE) reported Q3 EPS of ($0.46), $0.02 better than the analyst estimate of ($0.48). Revenue for the quarter came in at $1.85 million versus the consensus estimate of $1.55 million.

For earnings history and earnings-related data on Viveve Medical (VIVE) click here.

You May Also Be Interested In

• KB Home (KBH) Tops Q3 EPS by 16c
• MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
• AnaptysBio, Inc. (ANAB) Tops Q2 EPS by 524c